Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
orosresearch.com
Samples
Passed
Failed
Trust score updated: June 3, 2026 · 100% pass rate
Composite score based on 37 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 37 COAs attributed to this vendor. Last recomputed 2026-06-03.
High-purity research peptides made in California. Your trusted source for 7-point tested, American-made peptides. Science without Shortcuts™. Founded in 2025.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 18, 2026 | CJC-1295 without DAC | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LP-CJCND5-526-B5 · Report 26EA0512-008 |
| May 18, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA10-526-B9 · Report 26EA0512-010 |
| May 18, 2026 | N-Acetyl Semax Amidate | HPLC purity | PASS | 99% | Ethos Analytics |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Full identity on file (0.03), Clean presence (0.03)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot OR-LPNASMX30-526-B2 · Report 26EA0515-043 |
| May 18, 2026 | Gut Matrix | Identity & safety panels | PASS | -- | Ethos Analytics | Lot OR-CGMTX201-526-B1 · Report 26EA0512-011 |
| May 18, 2026 | N-Acetyl Selank Amidate | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPNASLK10-526-B2 · Report 26EA0515-044 |
| May 18, 2026 | BPC-157 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPC5-526-B5 · Report 26EA0515-042 |
| May 18, 2026 | DSIP | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPDSP5-526-B2 · Report 26EA0515-041 |
| May 18, 2026 | 5-Amino-1MQ | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LP5A150-526-B1 · Report 26EA0515-040 |
| May 18, 2026 | BPC-157 Arginate | Identity & safety panels | PASS | -- | Ethos Analytics | Lot OR-CBPC500-526-B2 · Report 26EA0512-012 |
| May 18, 2026 | Tesamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTES5-526-B6 · Report 26EA0515-038 |
| May 18, 2026 | KLOW (GHK-Cu / BPC-157/ TB-500 / KPV) | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPKLO80-526-B4 · Report 26EA0512-007 |
| May 18, 2026 | SS-31/MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSSMC20-526-B2 · Report 26EA0512-009 |
| May 18, 2026 | Epithalon | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPEPI10-526-B2 · Report 26EA0515-039 |
| Apr 16, 2026 | BPC-157 / TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPCTB10-426-B4 · Report 26EA0410-037 |
| Apr 16, 2026 | CJC-1295 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJC5-426-B5 · Report 26EA0410-032 |
| Apr 16, 2026 | Semaglutide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPS10-426-B3 · Report 26EA0410-033 |
| Apr 16, 2026 | KPV | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPKPV15-426-B2 · Report 26EA0410-027 |
| Apr 16, 2026 | Melanotan-2 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPMT2-426-B5 · Report 26EA0410-030 |
| Apr 16, 2026 | Sermorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSERM5-426-B4 · Report 26EA0410-036 |
| Apr 16, 2026 | Tesamorelin/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTESIPA20-426-B3 · Report 26EA0410-034 |
| Apr 16, 2026 | Tirzepatide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPT10-426-B3 · Report 26EA0410-029 |
| Apr 16, 2026 | Tirzepatide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPT5-426-B2 · Report 26EA0410-028 |
| Apr 16, 2026 | Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPIPA5-426-B4 · Report 26EA0410-031 |
| Apr 16, 2026 | MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPMOTS10-426-B7 · Report 26EA0410-035 |
| Apr 9, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA20-326-B2 · Report 26EA0403-012 |
| Apr 9, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPCTB20-326-B4 · Report 26EA0403-013 |
| Apr 9, 2026 | AOD-9604 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPAOD5-326-B2 · Report 26EA0403-014 |
| Apr 9, 2026 | Tesamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTES5-326-B5 · Report 26EA0403-020 |
| Apr 9, 2026 | N-Acetyl Semax/N-Acetyl Selank | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPNASMSL15-326-B2 · Report 26EA0403-019 |
| Apr 9, 2026 | Thymosin Alpha-1 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTA5-326-B1 · Report 26EA0403-018 |
| Apr 9, 2026 | TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTB10-326-B5 · Report 26EA0403-017 |
| Apr 9, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA10-326-B8 · Report 26EA0403-011 |
| Apr 9, 2026 | BPC-157 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPC10-326-B5 · Report 26EA0403-016 |
| Apr 9, 2026 | Epithalon | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPEPI10-326-B2 · Report 26EA0403-015 |
| Apr 9, 2026 | Retatrutide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPR10-326-B2 · Report 26EA0403-010 |
| Apr 9, 2026 | KLOW (GHK-Cu / BPC-157/ TB-500 / KPV) | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPKLO80-326-B3 · Report 26EA0403-022 |
| Apr 9, 2026 | SS-31/MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSSMC20-326-B1 · Report 26EA0403-021 |
| Jun 4, 2026 | — | Identity & safety panels | PASS | -- | — |
| Jun 4, 2026 | — | Identity & safety panels | PASS | -- | — |
| Jun 4, 2026 | — | Identity & safety panels | PASS | -- | — |
| Jun 4, 2026 | — | Identity & safety panels | PASS | -- | — |
| Jun 4, 2026 | — | Identity & safety panels | PASS | -- | — |